Expanding the clinical phenotype of nuclear matrix protein 2 antibody-positive dermatomyositis

Michelle Toker; Roya S Nazarian; Pooja Srivastava; Bijal Amin; Benedict Wu

doi:10.1016/j.jdcr.2023.01.019

Expanding the clinical phenotype of nuclear matrix protein 2 antibody-positive dermatomyositis

JAAD Case Rep. 2023 Feb 3:33:77-80. doi: 10.1016/j.jdcr.2023.01.019. eCollection 2023 Mar.

Authors

Michelle Toker¹, Roya S Nazarian¹, Pooja Srivastava², Bijal Amin^{1

2}, Benedict Wu¹

Affiliations

¹ Division of Dermatology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
² Department of Pathology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.

No abstract available

Keywords: ACR, American College of Rheumatology; DM, dermatomyositis; EULAR, European Alliance of Associations for Rheumatology; NXP-2, nuclear matrix protein 2; autoimmune connective tissue disease; dermatomyositis; inflammatory disease; morphology; nuclear matrix protein 2 (NXP-2); rash.

Publication types

Case Reports